← Mechanisms of action
SCN5A
SINGLE PROTEINHomo sapiens
Preferred name: Sodium channel protein type V alpha subunit ChEMBL ↗
Linked proteins
Drugs acting on this target (10)
| Active Pharmaceutical Ingredient | Mechanism Type ▲ | Approval Status | API Type | Mechanism of Action |
|---|---|---|---|---|
| eucaine | Antagonist | marketed | Small molecule | SCN5A antagonist |
| azd-1305 | Blocker | experimental | Small molecule | SCN5A blocker |
| azd7009 | Blocker | experimental | Small molecule | SCN5A blocker |
| cifenline succinate | Blocker | experimental | Small molecule | SCN5A blocker |
| cinchocaine (nupercaine) | Blocker | approved | Small molecule | SCN5A blocker |
| flecainide (tambocor) | Blocker | approved | Small molecule | SCN5A blocker |
| prenylamine | Blocker | experimental | Small molecule | SCN5A blocker |
| ranolazine (ranexa) | Blocker | approved | Small molecule | SCN5A blocker |
| vernakalant | Blocker | experimental | Small molecule | Sodium channel protein type V alpha subunit blocker |
| eleclazine | Inhibitor | experimental | Small molecule | SCN5A inhibitor |